Intuitive Surgical, Inc. vs iShares iBoxx $ Inv Grade Corporate Bond ETF — how do they compare? Intuitive Surgical, Inc. trades at $425.25 (market cap $146.76B), while iShares iBoxx $ Inv Grade Corporate Bond ETF trades at $102.41 (market cap $28.50B). The key difference: Intuitive Surgical, Inc. is far larger — about 5.1× iShares iBoxx $ Inv Grade Corporate Bond ETF's market cap, and Intuitive Surgical, Inc. is trading nearer its 52-week high, iShares iBoxx $ Inv Grade Corporate Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and iShares iBoxx $ Inv Grade Corporate Bond ETF for 125 Days on average.
| ISRG | LQD | |
|---|---|---|
Market Cap | $146.76B | $28.50B |
Volume | 2,529,814 | 37,320,110 |
Sector | Health | Fixed Income |
52-Week High | $592.85 | $112.91 |
52-Week Low | $332.02 | $101.83 |
Typical Hold Time | 84 Days | 125 Days |
Enterprise Value | $141.54B | — |
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $424.58, up 2.43% with strong bullish momentum. The stock shows robust fundamentals with revenue growing from $6.2B in 2022 to $10.1B in 2025 and net profit margins exceeding 28%. Recent earnings consistently beat expectations, with Q2 2026 EPS of $2.80 surpassing the $2.48 forecast. Technical indicators show bullish moving averages with support at $410 and resistance at $419. Analyst consensus remains strongly positive with 70% buy ratings and a $480.78 price target.
ISRG maintains a dominant position in robotic surgery with expanding international growth offsetting China headwinds. The primary investment opportunity lies in continued procedure growth and da Vinci 5 adoption, though risks include competitive pressures and affordability concerns. With strong cash flow generation and institutional support, the stock presents upside potential despite premium valuations.
LQD, the iShares iBoxx $ Investment Grade Corporate Bond ETF, trades at $102.295, up slightly by 0.17% on the day. The technical outlook is bearish, with moving averages signaling selling pressure, while oscillators are neutral. Recent news highlights a significant increase in short interest and a challenging environment for bonds due to rising yields. The fund maintains a 4.8% yield, with recent dividend payments, but faces headwinds from higher interest rates impacting corporate borrowing costs.
The outlook for LQD is cautious amid a rising rate environment, which pressures bond prices. Investment opportunities lie in its high-quality corporate bond portfolio and steady yield, but risks include further yield increases and economic slowdowns affecting credit quality. Investors should weigh the fund's income generation against interest rate sensitivity and market volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index. The underlying index is designed to provide a broad representation of the US dollar-denominated liquid investment-grade corporate bond market.
Read more on LQD →